Comparing Nutanix (NASDAQ:NTNX) and Firefly Neuroscience (NASDAQ:AIFF)

Nutanix (NASDAQ:NTNX) and Firefly Neuroscience (NASDAQ:AIFF) are both computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, profitability, valuation and risk.

Analyst Recommendations

This is a summary of current ratings and price targets for Nutanix and Firefly Neuroscience, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nutanix	0	3	12	0	2.80
Firefly Neuroscience	0	0	0	0	0.00

Nutanix currently has a consensus price target of $79.50, indicating a potential upside of 12.81%. Given Nutanix’s stronger consensus rating and higher possible upside, analysts clearly believe Nutanix is more favorable than Firefly Neuroscience.

Risk & Volatility

Nutanix has a beta of 1.17, meaning that its stock price is 17% more volatile than the S&P 500. Comparatively, Firefly Neuroscience has a beta of 3.06, meaning that its stock price is 206% more volatile than the S&P 500.

Profitability

This table compares Nutanix and Firefly Neuroscience’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nutanix	-3.54%	-12.28%	3.30%
Firefly Neuroscience	-73.72%	-276.50%	-133.02%

Earnings and Valuation

This table compares Nutanix and Firefly Neuroscience”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nutanix	$2.23 billion	8.47	-$124.78 million	($0.35)	-201.34
Firefly Neuroscience	$7.98 million	8.98	-$2.03 million	N/A	N/A

Firefly Neuroscience has lower revenue, but higher earnings than Nutanix.

Insider and Institutional Ownership

85.3% of Nutanix shares are owned by institutional investors. Comparatively, 5.0% of Firefly Neuroscience shares are owned by institutional investors. 6.8% of Nutanix shares are owned by insiders. Comparatively, 8.4% of Firefly Neuroscience shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Nutanix beats Firefly Neuroscience on 8 of the 12 factors compared between the two stocks.

About Nutanix

Nutanix, Inc. engages in the provision of a cloud platform leveraging web-scale engineering and consumer-grade design. It operates through the following geographic segments: United States, Europe, the Middle East, Africa, Asia Pacific, and Other Americas. The firm also provides software solutions and cloud services to customers’ enterprise infrastructure. The company was founded by Dheeraj Pandey, Ajeet Singh, and Mohit Aron in 2009 and is headquartered in San Jose, CA.

About Firefly Neuroscience

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.